Biomarkers of acute lung injury: worth their salt?
Open Access
- 12 December 2011
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 9 (1) , 132
Abstract
The validation of biomarkers has become a key goal of translational biomedical research. The purpose of this article is to discuss the role of biomarkers in the management of acute lung injury (ALI) and related research. Biomarkers should be sensitive and specific indicators of clinically important processes and should change in a relevant timeframe to affect recruitment to trials or clinical management. We do not believe that they necessarily need to reflect pathogenic processes. We critically examined current strategies used to identify biomarkers and which, owing to expedience, have been dominated by reanalysis of blood derived markers from large multicenter Phase 3 studies. Combining new and existing validated biomarkers with physiological and other data may add predictive power and facilitate the development of important aids to research and therapy.Keywords
This publication has 69 references indexed in Scilit:
- Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injuryCritical Care Medicine, 2011
- Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung InjuryCritical Care Clinics, 2011
- A stepwise approach to justify phase III randomized clinical trials and enhance the likelihood of a positive resultCritical Care Medicine, 2010
- Epithelial repair mechanisms in the lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- A simple clinical predictive index for objective estimates of mortality in acute lung injury*Critical Care Medicine, 2009
- Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injuryIntensive Care Medicine, 2008
- Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injuryThorax, 2008
- From evidence to clinical practice: Effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest*Critical Care Medicine, 2006
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004